rcellminerData
Bioc currentrcellminerData: Molecular Profiles and Drug Response for the NCI-60 Cell Lines
Release Lineage
Entered 3.1 · Apr 17, 2015
Current · Requires R 4.6
Description
The NCI-60 cancer cell line panel has been used over the course of several decades as an anti-cancer drug screen. This panel was developed as part of the Developmental Therapeutics Program (DTP, http://dtp.nci.nih.gov/) of the U.S. National Cancer Institute (NCI). Thousands of compounds have been tested on the NCI-60, which have been extensively characterized by many platforms for gene and protein expression, copy number, mutation, and others (Reinhold, et al., 2012). The purpose of the CellMiner project (http://discover.nci.nih.gov/ cellminer) has been to integrate data from multiple platforms used to analyze the NCI-60 and to provide a powerful suite of tools for exploration of NCI-60 data.
Code & tests
Open call graph →Code intelligence has not been computed for this package yet.
Code
Code metrics have not been computed for this package yet.
Topics
Depended on by (1)
Bioconductor (1)
People
Augustin Luna